19 October 2015Patents

WIPR survey: readers back TPP data exclusivity period

A five-year period of data exclusivity available for biological drugs, as proposed in the Trans-Pacific Partnership (TPP) is long enough to encourage investment in the field, readers have said.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk